| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | pyrophosphatase activity | RAN ENPP1 ACTB CHD9 MCM4 MCM7 RAB38 NUDT11 DDX46 RUVBL1 ABCB10 ABCB8 NUDT10 DDX20 ATP13A3 KIF13A KIF17 | 2.56e-06 | 839 | 108 | 17 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RAN ENPP1 ACTB CHD9 MCM4 MCM7 RAB38 NUDT11 DDX46 RUVBL1 ABCB10 ABCB8 NUDT10 DDX20 ATP13A3 KIF13A KIF17 | 2.60e-06 | 840 | 108 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RAN ENPP1 ACTB CHD9 MCM4 MCM7 RAB38 NUDT11 DDX46 RUVBL1 ABCB10 ABCB8 NUDT10 DDX20 ATP13A3 KIF13A KIF17 | 2.60e-06 | 840 | 108 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ACTB CHD9 MCM4 MCM7 DDX46 RUVBL1 ABCB10 ABCB8 DDX20 ATP13A3 KIF13A KIF17 | 4.77e-06 | 441 | 108 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | glutamate receptor activity | 1.29e-05 | 27 | 108 | 4 | GO:0008066 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO5A ACTB CHD9 MCM4 MCM7 DDX46 RUVBL1 ABCB10 ABCB8 DDX20 ATP13A3 KIF13A KIF17 | 2.74e-05 | 614 | 108 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RAN ACTB CHD9 MCM4 MCM7 RAB38 DDX46 RUVBL1 ABCB10 ABCB8 DDX20 ATP13A3 KIF13A KIF17 | 7.45e-05 | 775 | 108 | 14 | GO:0017111 |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 9.90e-05 | 17 | 108 | 3 | GO:0004970 | |
| GeneOntologyMolecularFunction | linoleic acid epoxygenase activity | 1.73e-04 | 4 | 108 | 2 | GO:0071614 | |
| GeneOntologyMolecularFunction | helicase activity | 2.20e-04 | 158 | 108 | 6 | GO:0004386 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 2.56e-04 | 57 | 108 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | endopolyphosphatase activity | 2.87e-04 | 5 | 108 | 2 | GO:0000298 | |
| GeneOntologyMolecularFunction | bis(5'-adenosyl)-hexaphosphatase activity | 2.87e-04 | 5 | 108 | 2 | GO:0034431 | |
| GeneOntologyMolecularFunction | diphosphoinositol-polyphosphate diphosphatase activity | 2.87e-04 | 5 | 108 | 2 | GO:0008486 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 3.13e-04 | 60 | 108 | 4 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 4.25e-04 | 65 | 108 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 4.25e-04 | 65 | 108 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | bis(5'-adenosyl)-pentaphosphatase activity | 4.29e-04 | 6 | 108 | 2 | GO:0034432 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 6.81e-04 | 32 | 108 | 3 | GO:0005452 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 7.32e-04 | 75 | 108 | 4 | GO:0098960 | |
| GeneOntologyMolecularFunction | transcription factor binding | TRIB2 ACTB PIAS1 MEIS2 STAT5A STAT5B WIZ RUVBL1 UBN1 MTOR DDX20 PRDM16 | 7.69e-04 | 753 | 108 | 12 | GO:0008134 |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 7.94e-04 | 8 | 108 | 2 | GO:0004972 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 8.09e-04 | 77 | 108 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 1.54e-03 | 11 | 108 | 2 | GO:0098973 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 2.13e-03 | 100 | 108 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 2.37e-03 | 49 | 108 | 3 | GO:0140359 | |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 2.53e-03 | 14 | 108 | 2 | GO:0008401 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | EPRS1 MYO5A SGCB ENPP1 ACTB GRB7 CASP7 APLP1 GRIN2A NSMCE3 CHRNA1 STAT5A STAT5B NAMPT MTOR | 6.13e-06 | 752 | 105 | 15 | GO:1901699 |
| GeneOntologyBiologicalProcess | regulation of erythrocyte differentiation | 1.36e-05 | 60 | 105 | 5 | GO:0045646 | |
| GeneOntologyBiologicalProcess | positive regulation of gamma-delta T cell differentiation | 2.73e-05 | 12 | 105 | 3 | GO:0045588 | |
| GeneOntologyBiologicalProcess | positive regulation of erythrocyte differentiation | 3.68e-05 | 37 | 105 | 4 | GO:0045648 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 3.80e-05 | 180 | 105 | 7 | GO:0015698 | |
| GeneOntologyBiologicalProcess | positive regulation of gamma-delta T cell activation | 4.48e-05 | 14 | 105 | 3 | GO:0046645 | |
| GeneOntologyBiologicalProcess | regulation of gamma-delta T cell differentiation | 5.58e-05 | 15 | 105 | 3 | GO:0045586 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to cell periphery | 6.21e-05 | 82 | 105 | 5 | GO:1904377 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular associated smooth muscle contraction | 7.68e-05 | 3 | 105 | 2 | GO:1904694 | |
| GeneOntologyBiologicalProcess | development of secondary male sexual characteristics | 7.68e-05 | 3 | 105 | 2 | GO:0046544 | |
| GeneOntologyBiologicalProcess | regulation of gamma-delta T cell activation | 8.28e-05 | 17 | 105 | 3 | GO:0046643 | |
| GeneOntologyBiologicalProcess | regulation of myeloid cell differentiation | 1.13e-04 | 288 | 105 | 8 | GO:0045637 | |
| GeneOntologyBiologicalProcess | gamma-delta T cell differentiation | 1.37e-04 | 20 | 105 | 3 | GO:0042492 | |
| GeneOntologyBiologicalProcess | cellular response to peptide hormone stimulus | 1.44e-04 | 381 | 105 | 9 | GO:0071375 | |
| GeneOntologyBiologicalProcess | regulation of transepithelial transport | 1.53e-04 | 4 | 105 | 2 | GO:0150111 | |
| GeneOntologyBiologicalProcess | positive regulation of B cell differentiation | 1.59e-04 | 21 | 105 | 3 | GO:0045579 | |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 2.33e-04 | 59 | 105 | 4 | GO:0007215 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to cell periphery | 2.43e-04 | 171 | 105 | 6 | GO:1904375 | |
| GeneOntologyBiologicalProcess | adenosine 5'-(hexahydrogen pentaphosphate) metabolic process | 2.54e-04 | 5 | 105 | 2 | GO:1901910 | |
| GeneOntologyBiologicalProcess | adenosine 5'-(hexahydrogen pentaphosphate) catabolic process | 2.54e-04 | 5 | 105 | 2 | GO:1901911 | |
| GeneOntologyBiologicalProcess | diadenosine pentaphosphate catabolic process | 2.54e-04 | 5 | 105 | 2 | GO:1901907 | |
| GeneOntologyBiologicalProcess | diadenosine pentaphosphate metabolic process | 2.54e-04 | 5 | 105 | 2 | GO:1901906 | |
| GeneOntologyBiologicalProcess | diadenosine hexaphosphate catabolic process | 2.54e-04 | 5 | 105 | 2 | GO:1901909 | |
| GeneOntologyBiologicalProcess | diadenosine hexaphosphate metabolic process | 2.54e-04 | 5 | 105 | 2 | GO:1901908 | |
| GeneOntologyBiologicalProcess | diphosphoinositol polyphosphate metabolic process | 2.54e-04 | 5 | 105 | 2 | GO:0071543 | |
| GeneOntologyBiologicalProcess | pigment biosynthetic process | 3.00e-04 | 63 | 105 | 4 | GO:0046148 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | FMO2 CYP2C9 CYP2C18 MYO5A ENPP1 AS3MT STAT5A STAT5B ARG1 MTOR ASNS HAL SLC4A4 ALDH5A1 TNXB | 3.15e-04 | 1064 | 105 | 15 | GO:0006082 |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 3.43e-04 | 27 | 105 | 3 | GO:0035235 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 3.80e-04 | 67 | 105 | 4 | GO:0019748 | |
| GeneOntologyBiologicalProcess | diadenosine polyphosphate catabolic process | 3.80e-04 | 6 | 105 | 2 | GO:0015961 | |
| GeneOntologyBiologicalProcess | premeiotic DNA replication | 3.80e-04 | 6 | 105 | 2 | GO:0006279 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | 3.80e-04 | 531 | 105 | 10 | GO:0042692 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 4.33e-04 | 124 | 105 | 5 | GO:0001910 | |
| GeneOntologyBiologicalProcess | vascular associated smooth muscle cell migration | 4.49e-04 | 70 | 105 | 4 | GO:1904738 | |
| GeneOntologyBiologicalProcess | cellular response to insulin stimulus | 4.76e-04 | 271 | 105 | 7 | GO:0032869 | |
| GeneOntologyBiologicalProcess | associative learning | 5.37e-04 | 130 | 105 | 5 | GO:0008306 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 5.76e-04 | 132 | 105 | 5 | GO:0035249 | |
| GeneOntologyBiologicalProcess | positive regulation of myeloid cell differentiation | 6.17e-04 | 134 | 105 | 5 | GO:0045639 | |
| GeneOntologyBiologicalProcess | gamma-delta T cell activation | 6.26e-04 | 33 | 105 | 3 | GO:0046629 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 2.17e-05 | 32 | 108 | 4 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 2.17e-05 | 32 | 108 | 4 | GO:0043189 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 8.53e-05 | 45 | 108 | 4 | GO:1902562 | |
| GeneOntologyCellularComponent | postsynaptic actin cytoskeleton | 1.22e-04 | 19 | 108 | 3 | GO:0098871 | |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 3.20e-04 | 26 | 108 | 3 | GO:0099571 | |
| GeneOntologyCellularComponent | dense body | 5.46e-04 | 7 | 108 | 2 | GO:0097433 | |
| GeneOntologyCellularComponent | NMDA selective glutamate receptor complex | 9.30e-04 | 9 | 108 | 2 | GO:0017146 | |
| GeneOntologyCellularComponent | podosome | 1.24e-03 | 41 | 108 | 3 | GO:0002102 | |
| GeneOntologyCellularComponent | MCM complex | 1.41e-03 | 11 | 108 | 2 | GO:0042555 | |
| GeneOntologyCellularComponent | CMG complex | 1.41e-03 | 11 | 108 | 2 | GO:0071162 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.44e-03 | 94 | 108 | 4 | GO:0000123 | |
| HumanPheno | Cerebral cortical hemiatrophy | 8.17e-06 | 6 | 39 | 3 | HP:0100308 | |
| Domain | DOCK_N | 1.81e-06 | 5 | 107 | 3 | PF16172 | |
| Domain | DOCK_N | 1.81e-06 | 5 | 107 | 3 | IPR032376 | |
| Domain | DHR-1_domain | 2.92e-05 | 11 | 107 | 3 | IPR027007 | |
| Domain | DHR_2 | 2.92e-05 | 11 | 107 | 3 | PS51651 | |
| Domain | DHR_1 | 2.92e-05 | 11 | 107 | 3 | PS51650 | |
| Domain | DHR-2 | 2.92e-05 | 11 | 107 | 3 | PF06920 | |
| Domain | DOCK | 2.92e-05 | 11 | 107 | 3 | IPR026791 | |
| Domain | DOCK_C | 2.92e-05 | 11 | 107 | 3 | IPR010703 | |
| Domain | DOCK-C2 | 2.92e-05 | 11 | 107 | 3 | PF14429 | |
| Domain | DHR-2 | 2.92e-05 | 11 | 107 | 3 | IPR027357 | |
| Domain | Peripla_BP_I | 7.18e-05 | 39 | 107 | 4 | IPR028082 | |
| Domain | Lig_chan-Glu_bd | 1.40e-04 | 18 | 107 | 3 | PF10613 | |
| Domain | Glu/Gly-bd | 1.40e-04 | 18 | 107 | 3 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 1.40e-04 | 18 | 107 | 3 | SM00918 | |
| Domain | Iontro_rcpt | 1.40e-04 | 18 | 107 | 3 | IPR001320 | |
| Domain | Iono_rcpt_met | 1.40e-04 | 18 | 107 | 3 | IPR001508 | |
| Domain | Lig_chan | 1.40e-04 | 18 | 107 | 3 | PF00060 | |
| Domain | PBPe | 1.40e-04 | 18 | 107 | 3 | SM00079 | |
| Domain | SH2 | 2.88e-04 | 101 | 107 | 5 | PF00017 | |
| Domain | PKNOX/Meis_N | 3.22e-04 | 5 | 107 | 2 | IPR032453 | |
| Domain | Meis_PKNOX_N | 3.22e-04 | 5 | 107 | 2 | PF16493 | |
| Domain | SH2 | 4.27e-04 | 110 | 107 | 5 | SM00252 | |
| Domain | SH2 | 4.45e-04 | 111 | 107 | 5 | PS50001 | |
| Domain | SH2 | 4.63e-04 | 112 | 107 | 5 | IPR000980 | |
| Domain | - | 4.63e-04 | 112 | 107 | 5 | 3.30.505.10 | |
| Domain | MCM_N | 4.80e-04 | 6 | 107 | 2 | PF14551 | |
| Domain | MCM_CS | 4.80e-04 | 6 | 107 | 2 | IPR018525 | |
| Domain | MCM_N | 4.80e-04 | 6 | 107 | 2 | IPR027925 | |
| Domain | STAT_TF_DNA-bd_sub | 6.70e-04 | 7 | 107 | 2 | IPR012345 | |
| Domain | STAT | 6.70e-04 | 7 | 107 | 2 | IPR001217 | |
| Domain | STAT_int | 6.70e-04 | 7 | 107 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 6.70e-04 | 7 | 107 | 2 | IPR013801 | |
| Domain | STAT_bind | 6.70e-04 | 7 | 107 | 2 | PF02864 | |
| Domain | STAT_int | 6.70e-04 | 7 | 107 | 2 | PF02865 | |
| Domain | - | 6.70e-04 | 7 | 107 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 6.70e-04 | 7 | 107 | 2 | PF01017 | |
| Domain | - | 6.70e-04 | 7 | 107 | 2 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 6.70e-04 | 7 | 107 | 2 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 6.70e-04 | 7 | 107 | 2 | IPR015988 | |
| Domain | - | 6.70e-04 | 7 | 107 | 2 | 2.60.40.630 | |
| Domain | E-NPP | 6.70e-04 | 7 | 107 | 2 | IPR024873 | |
| Domain | Actin | 7.31e-04 | 31 | 107 | 3 | IPR004000 | |
| Domain | Actin | 7.31e-04 | 31 | 107 | 3 | PF00022 | |
| Domain | ACTIN | 7.31e-04 | 31 | 107 | 3 | SM00268 | |
| Domain | STAT_TF_alpha | 8.90e-04 | 8 | 107 | 2 | IPR013800 | |
| Domain | MCM_OB | 8.90e-04 | 8 | 107 | 2 | PF17207 | |
| Domain | ACTINS_1 | 8.90e-04 | 8 | 107 | 2 | PS00406 | |
| Domain | MCM_OB | 8.90e-04 | 8 | 107 | 2 | IPR033762 | |
| Domain | MCM_2 | 8.90e-04 | 8 | 107 | 2 | PS50051 | |
| Domain | MCM_1 | 8.90e-04 | 8 | 107 | 2 | PS00847 | |
| Domain | P-loop_NTPase | RAN MYO5A CHD9 MCM4 MCM7 RAB38 DDX46 RUVBL1 ABCB10 ABCB8 DDX20 KIF13A KIF17 | 1.12e-03 | 848 | 107 | 13 | IPR027417 |
| Domain | MCM | 1.14e-03 | 9 | 107 | 2 | SM00350 | |
| Domain | MCM_dom | 1.14e-03 | 9 | 107 | 2 | IPR001208 | |
| Domain | MCM | 1.14e-03 | 9 | 107 | 2 | IPR031327 | |
| Domain | MCM | 1.14e-03 | 9 | 107 | 2 | PF00493 | |
| Domain | ANF_lig-bd_rcpt | 1.23e-03 | 37 | 107 | 3 | IPR001828 | |
| Domain | ANF_receptor | 1.23e-03 | 37 | 107 | 3 | PF01094 | |
| Domain | Phosphodiest/P_Trfase | 1.42e-03 | 10 | 107 | 2 | IPR002591 | |
| Domain | Phosphodiest | 1.42e-03 | 10 | 107 | 2 | PF01663 | |
| Domain | AAA | 1.44e-03 | 144 | 107 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 1.44e-03 | 144 | 107 | 5 | IPR003593 | |
| Domain | NUDIX_hydrolase_CS | 2.07e-03 | 12 | 107 | 2 | IPR020084 | |
| Domain | Mit_uncoupling | 2.07e-03 | 12 | 107 | 2 | IPR002030 | |
| Domain | Actin_CS | 3.70e-03 | 16 | 107 | 2 | IPR004001 | |
| Domain | Homeobox_KN | 4.18e-03 | 17 | 107 | 2 | PF05920 | |
| Domain | Homeobox_KN_domain | 4.18e-03 | 17 | 107 | 2 | IPR008422 | |
| Domain | ACTINS_2 | 4.18e-03 | 17 | 107 | 2 | PS00432 | |
| Domain | Actin/actin-like_CS | 4.69e-03 | 18 | 107 | 2 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 5.22e-03 | 19 | 107 | 2 | PS01132 | |
| Pathway | WP_INTERFERON_TYPE_I_SIGNALING | 1.99e-05 | 54 | 87 | 5 | M39435 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 4.11e-05 | 103 | 87 | 6 | MM14752 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 4.83e-05 | 106 | 87 | 6 | M27077 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 7.26e-05 | 114 | 87 | 6 | MM14814 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 7.65e-05 | 37 | 87 | 4 | MM14564 | |
| Pathway | REACTOME_PARASITE_INFECTION | 8.00e-05 | 116 | 87 | 6 | M29843 | |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 1.15e-04 | 41 | 87 | 4 | M39655 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 1.39e-04 | 43 | 87 | 4 | M508 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 1.52e-04 | 44 | 87 | 4 | M27934 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 1.73e-04 | 18 | 87 | 3 | M48098 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 2.32e-04 | 49 | 87 | 4 | M891 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | DOCK1 RPS6KA5 ACTB GRB7 ACTG1 STAT5A STAT5B MTOR VAV1 NCKAP1L | 2.46e-04 | 418 | 87 | 10 | MM15587 |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 2.52e-04 | 143 | 87 | 6 | M27107 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.84e-04 | 94 | 87 | 5 | M2843 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 3.72e-04 | 5 | 87 | 2 | M48987 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 3.72e-04 | 5 | 87 | 2 | M48986 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANXA2_S100A10_REGULATED_ACTIN_CYTOSKELETON | 3.72e-04 | 5 | 87 | 2 | M49034 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY | 3.72e-04 | 5 | 87 | 2 | M49006 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 3.72e-04 | 5 | 87 | 2 | MM15655 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | DOCK1 RPS6KA5 ACTB GRB7 ACTG1 STAT5A STAT5B MTOR FGFR2 VAV1 NCKAP1L | 4.16e-04 | 532 | 87 | 11 | M27870 |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 4.73e-04 | 25 | 87 | 3 | M27865 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING | 4.76e-04 | 59 | 87 | 4 | M39350 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 5.56e-04 | 6 | 87 | 2 | MM15581 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 5.56e-04 | 6 | 87 | 2 | MM15621 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 5.97e-04 | 27 | 87 | 3 | MM14712 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION | 6.11e-04 | 63 | 87 | 4 | M39366 | |
| Pathway | PID_IL4_2PATHWAY | 6.48e-04 | 64 | 87 | 4 | M28 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 7.39e-04 | 29 | 87 | 3 | MM15219 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGD_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 7.39e-04 | 29 | 87 | 3 | M47717 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 7.39e-04 | 29 | 87 | 3 | M779 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 7.75e-04 | 7 | 87 | 2 | M27953 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 7.75e-04 | 7 | 87 | 2 | M47581 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 7.75e-04 | 7 | 87 | 2 | M47646 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 7.75e-04 | 7 | 87 | 2 | M47430 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5 | 7.75e-04 | 7 | 87 | 2 | M27907 | |
| Pathway | WP_RAC1PAK1P38MMP2_PATHWAY | 8.16e-04 | 68 | 87 | 4 | M39456 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING_PATHWAY | 9.60e-04 | 71 | 87 | 4 | MM15947 | |
| Pathway | WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME | 9.60e-04 | 71 | 87 | 4 | M39860 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 9.60e-04 | 71 | 87 | 4 | MM15604 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 9.89e-04 | 32 | 87 | 3 | M27491 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 1.01e-03 | 72 | 87 | 4 | M26954 | |
| Pathway | WP_CALORIC_RESTRICTION_AND_AGING | 1.03e-03 | 8 | 87 | 2 | M39743 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BREAK_INDUCED_REPLICATION | 1.03e-03 | 8 | 87 | 2 | M47840 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 1.07e-03 | 73 | 87 | 4 | MM16641 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 1.12e-03 | 74 | 87 | 4 | M41814 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.14e-03 | 261 | 87 | 7 | MM15676 | |
| Pathway | WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS | 1.18e-03 | 34 | 87 | 3 | M48081 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES | 1.18e-03 | 34 | 87 | 3 | MM15265 | |
| Pathway | WP_PROLACTIN_SIGNALING | 1.24e-03 | 76 | 87 | 4 | M39601 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.29e-03 | 35 | 87 | 3 | MM15109 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 1.32e-03 | 9 | 87 | 2 | M47397 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.32e-03 | 9 | 87 | 2 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.32e-03 | 9 | 87 | 2 | MM1419 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAB_C_D_TO_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 1.32e-03 | 9 | 87 | 2 | M47725 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.32e-03 | 9 | 87 | 2 | M8066 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.39e-03 | 270 | 87 | 7 | M15514 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES | 1.40e-03 | 36 | 87 | 3 | M27549 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.52e-03 | 37 | 87 | 3 | MM15102 | |
| Pathway | KEGG_MEDICUS_VARIANT_DELETED_DMD_TO_DYSTROPHIN_ASSOCIATED_PROTEIN_COMPLEX | 1.64e-03 | 10 | 87 | 2 | M47575 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.64e-03 | 10 | 87 | 2 | MM15112 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.64e-03 | 10 | 87 | 2 | M27898 | |
| Pathway | REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL | 1.64e-03 | 10 | 87 | 2 | MM14709 | |
| Pathway | REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS | 1.64e-03 | 10 | 87 | 2 | M41731 | |
| Pathway | REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL | 1.64e-03 | 10 | 87 | 2 | M27051 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 1.64e-03 | 10 | 87 | 2 | MM15618 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.67e-03 | 205 | 87 | 6 | M752 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 2.00e-03 | 11 | 87 | 2 | M22027 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 2.00e-03 | 11 | 87 | 2 | M27195 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 2.00e-03 | 11 | 87 | 2 | MM15578 | |
| Pathway | PID_RANBP2_PATHWAY | 2.00e-03 | 11 | 87 | 2 | M140 | |
| Pathway | REACTOME_GAP_JUNCTION_DEGRADATION | 2.00e-03 | 11 | 87 | 2 | MM14732 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 2.03e-03 | 213 | 87 | 6 | M18306 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 2.04e-03 | 87 | 87 | 4 | MM15915 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 2.04e-03 | 87 | 87 | 4 | MM15600 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 2.04e-03 | 41 | 87 | 3 | MM15162 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 2.13e-03 | 88 | 87 | 4 | M41810 | |
| Pathway | PID_TCPTP_PATHWAY | 2.19e-03 | 42 | 87 | 3 | M91 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 2.33e-03 | 219 | 87 | 6 | M29836 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 2.34e-03 | 150 | 87 | 5 | M39520 | |
| Pathway | REACTOME_UNWINDING_OF_DNA | 2.39e-03 | 12 | 87 | 2 | M3656 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 2.39e-03 | 12 | 87 | 2 | M27893 | |
| Pathway | REACTOME_GAP_JUNCTION_DEGRADATION | 2.39e-03 | 12 | 87 | 2 | M15243 | |
| Pathway | WP_AMINO_ACID_METABOLISM | 2.40e-03 | 91 | 87 | 4 | M39570 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 2.48e-03 | 152 | 87 | 5 | MM15834 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 2.50e-03 | 44 | 87 | 3 | MM14606 | |
| Pathway | WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS | 2.50e-03 | 44 | 87 | 3 | M39673 | |
| Pathway | BIOCARTA_MCM_PATHWAY | 2.81e-03 | 13 | 87 | 2 | MM1363 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAC_TO_ACTIN_SIGNALING_PATHWAY | 2.81e-03 | 13 | 87 | 2 | M47723 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_CDC42_SIGNALING_PATHWAY | 2.81e-03 | 13 | 87 | 2 | M47730 | |
| Pathway | WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING | 3.03e-03 | 47 | 87 | 3 | M39380 | |
| Pathway | WP_AMINO_ACID_METABOLISM | 3.15e-03 | 98 | 87 | 4 | MM15942 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 3.21e-03 | 48 | 87 | 3 | M26964 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 3.21e-03 | 48 | 87 | 3 | MM14589 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 3.21e-03 | 48 | 87 | 3 | M914 | |
| Pathway | WP_EGFEGFR_SIGNALING | 3.26e-03 | 162 | 87 | 5 | M39334 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 3.27e-03 | 14 | 87 | 2 | M27858 | |
| Pathway | PID_IL5_PATHWAY | 3.27e-03 | 14 | 87 | 2 | M135 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TCCP_TO_ACTIN_SIGNALING_PATHWAY | 3.27e-03 | 14 | 87 | 2 | M47729 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPT_TO_RAC_SIGNALING_PATHWAY | 3.27e-03 | 14 | 87 | 2 | M47726 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 3.27e-03 | 14 | 87 | 2 | MM15842 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | EPRS1 RAN ACTR10 ACTG1 CASP7 MCM4 MCM7 TUBA4A LSM1 STAT5B NUP205 NAMPT SH2D4A RUVBL1 MTOR RTRAF ASNS LRBA KIF13A RPL11 | 2.44e-08 | 1455 | 109 | 20 | 22863883 |
| Pubmed | EPRS1 ACTB MCM4 MCM7 NUP205 NAMPT DDX46 RUVBL1 MTOR RTRAF ASNS DDX20 LRBA | 1.10e-07 | 638 | 109 | 13 | 33239621 | |
| Pubmed | Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancer. | 1.20e-07 | 4 | 109 | 3 | 21464042 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | EPRS1 RAN ACTB MCM4 MCM7 LCP1 TUBA4A STAT5A NUP205 NAMPT DDX46 RUVBL1 ABCB10 RTRAF DDX20 LRBA SEC63 RPL11 | 1.47e-07 | 1318 | 109 | 18 | 30463901 |
| Pubmed | EPRS1 RAN DPP10 MYO5A ACTB MCM4 MCM7 PGRMC1 TUBA4A ARG1 RAB38 MYOF RUVBL1 RPL11 | 2.31e-07 | 803 | 109 | 14 | 36517590 | |
| Pubmed | 3.78e-07 | 383 | 109 | 10 | 29331416 | ||
| Pubmed | EPRS1 RAN ACTB MCM4 MCM7 PGRMC1 TUBA4A NAMPT RUVBL1 ABCB10 RTRAF DDX20 RPL11 | 4.71e-07 | 725 | 109 | 13 | 27025967 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPRS1 RAN MYO5A ACTR10 ACTB MCM4 MCM7 LCP1 PGRMC1 TUBA4A DDX46 RUVBL1 RTRAF ASNS DDX20 RPL11 | 6.07e-07 | 1149 | 109 | 16 | 35446349 |
| Pubmed | 6.48e-07 | 156 | 109 | 7 | 37108203 | ||
| Pubmed | 6.48e-07 | 156 | 109 | 7 | 26170170 | ||
| Pubmed | 6.52e-07 | 312 | 109 | 9 | 37120454 | ||
| Pubmed | Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease. | EPRS1 RAN ACTB ACTG1 PGRMC1 TUBA4A NUP205 RUVBL1 RTRAF RPL11 | 8.36e-07 | 418 | 109 | 10 | 32552912 |
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 9.24e-07 | 24 | 109 | 4 | 35746896 | |
| Pubmed | 1.04e-06 | 330 | 109 | 9 | 32529326 | ||
| Pubmed | EPRS1 RAN ACTB MCM4 MCM7 DDX46 RUVBL1 MTOR RTRAF FGFR2 RPL11 | 1.07e-06 | 538 | 109 | 11 | 28524877 | |
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | 1.09e-06 | 332 | 109 | 9 | 30595499 | |
| Pubmed | Identification of FBXO25-interacting proteins using an integrated proteomics approach. | 1.51e-06 | 112 | 109 | 6 | 20473970 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | EPRS1 MYO5A ACTB ACTG1 TUBA4A F13B NUP205 ARG1 MRTFB HAL RPL11 | 1.69e-06 | 564 | 109 | 11 | 21565611 |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 2.17e-06 | 268 | 109 | 8 | 33024031 | |
| Pubmed | EPRS1 RAN ACTB MCM4 MCM7 LCP1 STAT5B NUP205 RTRAF ASNS LRBA RPL11 | 2.36e-06 | 707 | 109 | 12 | 19738201 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 2.36e-06 | 271 | 109 | 8 | 32433965 | |
| Pubmed | AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis. | 3.40e-06 | 200 | 109 | 7 | 35546148 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.63e-06 | 202 | 109 | 7 | 33005030 | |
| Pubmed | EPRS1 RAN MYO5A ACTB ACTG1 MCM4 MCM7 PGRMC1 NUP205 MTOR DDX20 ATP13A3 LRBA RPL11 NCKAP1L | 3.78e-06 | 1168 | 109 | 15 | 19946888 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPRS1 RAN MYO5A ACTG1 MCM4 MCM7 PGRMC1 TUBA4A NUP205 ARG1 DDX46 RUVBL1 RTRAF RPL11 | 4.03e-06 | 1024 | 109 | 14 | 24711643 |
| Pubmed | 4.58e-06 | 506 | 109 | 10 | 30890647 | ||
| Pubmed | 4.85e-06 | 11 | 109 | 3 | 14597672 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EPRS1 CYP2C18 RPS6KA5 MCM4 NSMCE3 PGRMC1 MYOF DDX46 SH2D4A UBN1 MSL3 DDX20 | 5.92e-06 | 774 | 109 | 12 | 15302935 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | EPRS1 MCM4 MCM7 PGRMC1 RUVBL1 ABCB10 MTOR RTRAF ABCB8 UBR3 LRBA | 6.26e-06 | 647 | 109 | 11 | 26618866 |
| Pubmed | Enlarged dendritic spines and pronounced neophobia in mice lacking the PSD protein RICH2. | 6.45e-06 | 12 | 109 | 3 | 26969129 | |
| Pubmed | 6.70e-06 | 415 | 109 | 9 | 16385451 | ||
| Pubmed | 8.37e-06 | 13 | 109 | 3 | 21930703 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | EPRS1 RAN ACTB ACTG1 MCM4 MCM7 PGRMC1 TUBA4A NUP205 NAMPT RUVBL1 RTRAF ASNS DDX20 RPL11 | 9.11e-06 | 1257 | 109 | 15 | 37317656 |
| Pubmed | EPRS1 RAN CNOT11 ACTB ACTG1 CHD9 MCM4 RUVBL1 RTRAF ASNS ALDH5A1 RPL11 | 9.22e-06 | 809 | 109 | 12 | 32129710 | |
| Pubmed | 9.35e-06 | 327 | 109 | 8 | 31409639 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | EPRS1 RAN ACTB ACTG1 MCM4 NSMCE3 TUBA4A DDX46 WIZ RUVBL1 UBN1 RTRAF RPL11 | 9.46e-06 | 954 | 109 | 13 | 36373674 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EPRS1 RAN ACTG1 CASP7 MCM4 MCM7 PGRMC1 NUP205 NAMPT RUVBL1 MTOR RTRAF ASNS DDX20 SEC63 RPL11 | 9.53e-06 | 1425 | 109 | 16 | 30948266 |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 23151802 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 26999798 | ||
| Pubmed | Beta- and gamma-cytoplasmic actins are required for meiosis in mouse oocytes. | 9.73e-06 | 2 | 109 | 2 | 21778137 | |
| Pubmed | De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. | 9.73e-06 | 2 | 109 | 2 | 22366783 | |
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 9.73e-06 | 2 | 109 | 2 | 31443474 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 12377952 | ||
| Pubmed | Prenatal presentation and diagnosis of Baraitser-Winter syndrome using exome sequencing. | 9.73e-06 | 2 | 109 | 2 | 32588558 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 25468562 | ||
| Pubmed | A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. | 9.73e-06 | 2 | 109 | 2 | 21127177 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 16289657 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 25552366 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 25470773 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 27625340 | ||
| Pubmed | Constitutively active Stat5A and Stat5B promote adipogenesis. | 9.73e-06 | 2 | 109 | 2 | 21431790 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 28500076 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 21826656 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 7720707 | ||
| Pubmed | STAT5A and STAT5B have opposite correlations with drug response gene expression. | 9.73e-06 | 2 | 109 | 2 | 27264955 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 22159083 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 12689335 | ||
| Pubmed | Gene structure and upstream regulatory regions of human CYP2C9 and CYP2C18. | 9.73e-06 | 2 | 109 | 2 | 8333835 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 20008792 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 33199496 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 16502315 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 12217382 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24821571 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 3221869 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 31599926 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 10594041 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 21036145 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 10486277 | ||
| Pubmed | Identification of human STAT5-dependent gene regulatory elements based on interspecies homology. | 9.73e-06 | 2 | 109 | 2 | 16840779 | |
| Pubmed | The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. | 9.73e-06 | 2 | 109 | 2 | 15128421 | |
| Pubmed | STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. | 9.73e-06 | 2 | 109 | 2 | 30377054 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 23565285 | ||
| Pubmed | Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer. | 9.73e-06 | 2 | 109 | 2 | 32790723 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 18492722 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 10066807 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 10835485 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 35464049 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 18286195 | ||
| Pubmed | Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. | 9.73e-06 | 2 | 109 | 2 | 23773921 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 8631883 | ||
| Pubmed | Overexpression of motor protein KIF17 enhances spatial and working memory in transgenic mice. | 9.73e-06 | 2 | 109 | 2 | 12391294 | |
| Pubmed | Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. | 9.73e-06 | 2 | 109 | 2 | 11030348 | |
| Pubmed | Association between STAT5 polymorphisms and glioblastoma risk in Han Chinese population. | 9.73e-06 | 2 | 109 | 2 | 24878107 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 31356773 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 12847485 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 12835478 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 7568026 | ||
| Pubmed | Identification of STAT5A and STAT5B target genes in human T cells. | 9.73e-06 | 2 | 109 | 2 | 24497979 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 17536022 | ||
| Pubmed | STAT5 transcriptional activity is impaired by LIF in a mammary epithelial cell line. | 9.73e-06 | 2 | 109 | 2 | 17382296 | |
| Pubmed | STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferation. | 9.73e-06 | 2 | 109 | 2 | 17911616 | |
| Pubmed | STAT5 signaling in sexually dimorphic gene expression and growth patterns. | 9.73e-06 | 2 | 109 | 2 | 10486314 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 17599554 | ||
| Pubmed | MiR-21 is under control of STAT5 but is dispensable for mammary development and lactation. | 9.73e-06 | 2 | 109 | 2 | 24497923 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 27760377 | ||
| Pubmed | A Molecular Prospective for HIRA Complex Assembly and H3.3-Specific Histone Chaperone Function. | 9.73e-06 | 2 | 109 | 2 | 27871933 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24335105 | ||
| Pubmed | Brain STAT5 signaling modulates learning and memory formation. | 9.73e-06 | 2 | 109 | 2 | 29460051 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 21502360 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 6686106 | ||
| Cytoband | 10q24 | 1.49e-06 | 35 | 109 | 4 | 10q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q23 | 1.24e-03 | 195 | 109 | 4 | chr10q23 | |
| Cytoband | 8p21.2 | 1.62e-03 | 25 | 109 | 2 | 8p21.2 | |
| GeneFamily | SH2 domain containing | 7.07e-05 | 101 | 77 | 5 | 741 | |
| GeneFamily | TALE class homeoboxes and pseudogenes | 1.80e-04 | 26 | 77 | 3 | 526 | |
| GeneFamily | Actins | 2.66e-04 | 6 | 77 | 2 | 929 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 3.71e-04 | 7 | 77 | 2 | 1201 | |
| GeneFamily | MCM family | 6.32e-04 | 9 | 77 | 2 | 1085 | |
| GeneFamily | ATP binding cassette subfamily B | 9.60e-04 | 11 | 77 | 2 | 806 | |
| GeneFamily | Nudix hydrolase family | 4.65e-03 | 24 | 77 | 2 | 667 | |
| Coexpression | WENG_POR_DOSAGE | 7.13e-06 | 30 | 109 | 4 | MM1199 | |
| Coexpression | HSIAO_LIVER_SPECIFIC_GENES | 9.86e-06 | 249 | 109 | 8 | M13283 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_DN | 2.09e-05 | 200 | 109 | 7 | M6445 | |
| Coexpression | GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN | 2.09e-05 | 200 | 109 | 7 | M4533 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-07 | 182 | 109 | 7 | f5f42e23832d0210560009ce6fd8eee89751e252 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.85e-07 | 186 | 109 | 7 | e0a2ea4b46af742bc7c9b2072bb85e27d5c92712 | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 4.77e-07 | 192 | 109 | 7 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | control-Myeloid-Neutrophils_3|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.11e-07 | 194 | 109 | 7 | 2218e6677dc6781a6e4ef3a315f2298cc2cd9df2 | |
| ToppCell | PCW_05-06|World / Celltypes from embryonic and fetal-stage human lung | 5.67e-07 | 197 | 109 | 7 | 1527261e2017113d8546d382a38acbb84699d03e | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Early_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.06e-07 | 199 | 109 | 7 | d67f5ae05daf942fb79f5b962021f37f4e275f4d | |
| ToppCell | Control-Control-Myeloid-Neutrophil|Control / Disease, condition lineage and cell class | 6.27e-07 | 200 | 109 | 7 | 95c41f147a1594d49e73cb56d86d301c3115ce20 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 6.27e-07 | 200 | 109 | 7 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | LPS-antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.09e-06 | 178 | 109 | 6 | afcc92e8fe313c85eaf617cf4dbc3058da6c99d6 | |
| ToppCell | LPS-antiTNF-Myeloid-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.09e-06 | 178 | 109 | 6 | bd689205bc92cda5f71df64c2332ff76adcd84b4 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.51e-06 | 103 | 109 | 5 | e28236a064a7c86e99e7e2edb1eb777f6034a9b4 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.97e-06 | 183 | 109 | 6 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.35e-06 | 185 | 109 | 6 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.55e-06 | 186 | 109 | 6 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.75e-06 | 187 | 109 | 6 | ff26a533d310126521efe1d05cf8b9d32e524550 | |
| ToppCell | Non-neuronal-Postmitotic-Red_blood_cells-Low_Quality|World / Primary Cells by Cluster | 7.40e-06 | 190 | 109 | 6 | 31cf1367db5c04242621f7c98a10d094bc519e31 | |
| ToppCell | Non-neuronal-Postmitotic-Red_blood_cells|World / Primary Cells by Cluster | 7.40e-06 | 190 | 109 | 6 | f0b82334375749d917e440c493f10340c52ea13c | |
| ToppCell | Non-neuronal-Postmitotic-Red_blood_cells-Low_Quality-14|World / Primary Cells by Cluster | 7.40e-06 | 190 | 109 | 6 | feadd834d843f952aa7ced93899fd1f0868743df | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.85e-06 | 192 | 109 | 6 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.09e-06 | 193 | 109 | 6 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.33e-06 | 194 | 109 | 6 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.33e-06 | 194 | 109 | 6 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | severe-Myeloid-Neutrophils_3|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.33e-06 | 194 | 109 | 6 | 1f8edab1c8ba48bc0114429ea47aab378b5830b7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.33e-06 | 194 | 109 | 6 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.58e-06 | 195 | 109 | 6 | c5d2d9f12fd893331c9de261af30607d845d4f6a | |
| ToppCell | (1)_Dll4_loss-of-function|World / Stress and Cell class | 8.58e-06 | 195 | 109 | 6 | def4b2350e08a36ffddca71ea80ef611f2d437d9 | |
| ToppCell | (1)_Dll4_loss-of-function-(0)_LMPP_(LSK_cells)|World / Stress and Cell class | 8.58e-06 | 195 | 109 | 6 | f11cf4b6855a26ff6ea572eebaad2aad6bb2434b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.09e-06 | 197 | 109 | 6 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.09e-06 | 197 | 109 | 6 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | lymphoid-T_cell-Regulatory_T_cell|lymphoid / Lineage, cell class and subclass | 9.09e-06 | 197 | 109 | 6 | 73d5dcf076caae60ea32258b4e9dcac8979a661e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.09e-06 | 197 | 109 | 6 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.09e-06 | 197 | 109 | 6 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | COVID-19-Heart-Low_count_Fib|Heart / Disease (COVID-19 only), tissue and cell type | 9.36e-06 | 198 | 109 | 6 | aee3d8757642cd6bbf6dc03e78b3912c6b8e510a | |
| ToppCell | lymphoid-T_cell-Regulatory_T_cell|T_cell / Lineage, cell class and subclass | 9.36e-06 | 198 | 109 | 6 | 6773c6043ef4a3d9e9700330b6386431ee66abdc | |
| ToppCell | CD8+_Memory_T_cell-CV-2|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 9.63e-06 | 199 | 109 | 6 | 1e33d8e2e0d6a54ef6e2e13f986e19fd209275a8 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal-Neurons|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 9.63e-06 | 199 | 109 | 6 | ae575ed7582f2a4218f6cbcbf5f7f0ce7a5bc26b | |
| ToppCell | CV-Moderate-2|Moderate / Virus stimulation, Condition and Cluster | 9.63e-06 | 199 | 109 | 6 | 70d6f2a328eec4cb2cecb7cd85859fba9e15c9c8 | |
| ToppCell | CV-Mild-2|Mild / Virus stimulation, Condition and Cluster | 9.63e-06 | 199 | 109 | 6 | d88cc07053a852e6c468538a0a851ffa09f97a0d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Macroglial-Glia_progenitor_cell|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 9.91e-06 | 200 | 109 | 6 | 859f98f63797087e7df18be632de153009b6cab1 | |
| ToppCell | Calu_3-uninfected|Calu_3 / Cell line, Condition and Strain | 9.91e-06 | 200 | 109 | 6 | cb9b6a6b085ae0e19b450940c4ecd92406d8a2b3 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.91e-06 | 200 | 109 | 6 | ce969c958a31145bbfe315a9a865d7900ecc9549 | |
| ToppCell | 5'-GW_trimst-1|5' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.91e-06 | 200 | 109 | 6 | a4c6d0cccba7aee35eaedf29faff32b9494b6582 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.21e-05 | 121 | 109 | 5 | 5035e071033cb76a7fc0128716755b14821e8f05 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.21e-05 | 121 | 109 | 5 | c96115bd33455296378a257583b49442d00b39ca | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Stem_cells-neuroepithelial-like_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.91e-05 | 133 | 109 | 5 | bdaba11e8d9868eca57c3c976e381ee096d39ddf | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.63e-05 | 152 | 109 | 5 | 0652ee3443e6fbb679d2c4f326239ae7c803f924 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.50e-05 | 159 | 109 | 5 | 210ac7fa89514a84f38d9f42254e38fbc2bc5f42 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.63e-05 | 160 | 109 | 5 | c9fe3438f747e2a98e3f27a56ba4c12a3789c2f2 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.68e-05 | 167 | 109 | 5 | 5c3d0763f73628c71c71f9883556bb4f1639f3cc | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-05 | 173 | 109 | 5 | 8bffd512a4e561e23cc04478e2ca6fd5d3771fe4 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-05 | 173 | 109 | 5 | 3e3c61468e703330788a10d850ef41a85680f86d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-05 | 173 | 109 | 5 | 5bb11f9ef17213c9b99fdf92b444f5da3b25fc95 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Immature_Interneurons|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.28e-05 | 176 | 109 | 5 | 62870115e31170c8b42eec57c709e0fe32388b37 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.28e-05 | 176 | 109 | 5 | cb8fd56a4f935cdda19d7ab43382cdda7c307667 | |
| ToppCell | severe-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.47e-05 | 177 | 109 | 5 | d1ad35ee3d2a84b1d01126d0a38464ab858c00d0 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-GHRL+_NE_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.68e-05 | 178 | 109 | 5 | 32cc4155267baf1b536a61310044e6502d09531f | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.68e-05 | 178 | 109 | 5 | 50bb1f2c6a8d050ff2af217fd76c3b1b7b4a4a69 | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial-intermediate_mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.88e-05 | 179 | 109 | 5 | b1f085e4c8d65d5cdbfaf2db80343638abb08979 | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-05 | 179 | 109 | 5 | dfd9d29281510d32f1a2e8336d2e58ef496cfd1d | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.88e-05 | 179 | 109 | 5 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.88e-05 | 179 | 109 | 5 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.09e-05 | 180 | 109 | 5 | a682a5d55c612709c9ee9fa4289d6f8bef7fe1af | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.30e-05 | 181 | 109 | 5 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.30e-05 | 181 | 109 | 5 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.52e-05 | 182 | 109 | 5 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.52e-05 | 182 | 109 | 5 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.75e-05 | 183 | 109 | 5 | 317b756378a9efd8ecb754acf7273f83f996e106 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.75e-05 | 183 | 109 | 5 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.97e-05 | 184 | 109 | 5 | 9e5f98f9113e5e38bdadba6d9d2c346177fb35fe | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.97e-05 | 184 | 109 | 5 | fe9ea4d0e0be820e95eaf9bb42a5560d0e177574 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.97e-05 | 184 | 109 | 5 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.97e-05 | 184 | 109 | 5 | a12a6a481e78adc62da1904431f62b119f70b15f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.20e-05 | 185 | 109 | 5 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | LPS-antiTNF-Myeloid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.44e-05 | 186 | 109 | 5 | 839c6da5244f469461b2e5563e36162b2911cd01 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.44e-05 | 186 | 109 | 5 | 7950e03ea080238c168b9d807e217f459acdfb28 | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 9.68e-05 | 187 | 109 | 5 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.68e-05 | 187 | 109 | 5 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.68e-05 | 187 | 109 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | E15.5-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.68e-05 | 187 | 109 | 5 | 1288fcd0124c70711521f3ac83554e9acdd37cb2 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.93e-05 | 188 | 109 | 5 | e99e3765b48392c987cf0c5ccbded0655637d7b7 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.93e-05 | 188 | 109 | 5 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 189 | 109 | 5 | 3717d1148e26ac78a26aea0ca1dbfbb9d3668877 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.02e-04 | 189 | 109 | 5 | f75cebd4c3e54e297557449ba67ccc8d1a2a14f5 | |
| ToppCell | mild-Others|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.04e-04 | 190 | 109 | 5 | 782dc1b612ac1faad7cc2781bfda92a079830d38 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-04 | 190 | 109 | 5 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 190 | 109 | 5 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 191 | 109 | 5 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | 18-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 1.07e-04 | 191 | 109 | 5 | 86ce98d2c90c196474b06869de888cf5d1eed196 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.07e-04 | 191 | 109 | 5 | 5b6e1caf7827ee4e1f39ca25f04ebbf608952721 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.07e-04 | 191 | 109 | 5 | 48cffb55c71bb8b34e926fc461fcd345ce43ea00 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-04 | 191 | 109 | 5 | 47156e5f1d790707f42f6283104a44b33af613e5 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like-IPCs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.07e-04 | 191 | 109 | 5 | e4c1c533771b582e21683dbec6f93a558d865e00 | |
| ToppCell | ILEUM-non-inflamed-(1)_Tregs|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.07e-04 | 191 | 109 | 5 | e065d16a1f88c91dec576d248a318534ceab1cb2 | |
| ToppCell | mild-Others-Megakaryocytes|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.07e-04 | 191 | 109 | 5 | 0b36223bd7f5758cc37194da6cc252f613bc3c97 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 191 | 109 | 5 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells-Platelet|Megakaryo-cells / Lineage, cell class and subclass | 1.10e-04 | 192 | 109 | 5 | a061db719d87209b56d074afbdeab37aa0079419 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-IPC_like-IPCs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.10e-04 | 192 | 109 | 5 | bd91bf0ceeac49dc5a18aa2e401244db0ca596ae | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 192 | 109 | 5 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.10e-04 | 192 | 109 | 5 | 694626965faee8b7c4e5bb78d554f62ba8dbc423 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-IPC_like|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.10e-04 | 192 | 109 | 5 | 18fbf485ad762ba7a9ac3e19bad136b0cf3af3c5 | |
| Drug | glutamate | EPRS1 CLCA4 ACTB ACTG1 APLP1 GRIA4 GRIN2A GRM3 CHRNA1 ARG1 MTOR ASNS ABCB8 HAL GRIN3A SLC4A4 CABIN1 ALDH5A1 | 6.04e-07 | 962 | 108 | 18 | CID000000611 |
| Drug | racemethorphan | 7.84e-07 | 107 | 108 | 7 | CID000003008 | |
| Drug | Dopamine | 2.19e-06 | 240 | 108 | 9 | ctd:D004298 | |
| Drug | YM90K | 3.95e-06 | 23 | 108 | 4 | CID005486547 | |
| Drug | sodium nitroprusside | 4.34e-06 | 261 | 108 | 9 | CID000045469 | |
| Drug | ammonia | ACTB ACTG1 GRIN2A TUBA4A F13B ARG1 ASNS HAL SLC4A4 ALDH5A1 MOCS1 RPL11 | 5.46e-06 | 509 | 108 | 12 | CID000000222 |
| Drug | aspartate | CLCA4 CASP7 APLP1 GRIA4 GRIN2A GRM3 ARG1 DOCK5 ASNS HAL CABIN1 ALDH5A1 | 6.52e-06 | 518 | 108 | 12 | CID000000424 |
| Drug | melatonin | EPRS1 CYP2C9 CYP2C18 APLP1 GRIA4 GRIN2A GRM3 HHIP MTOR LRBA PRDM16 | 8.48e-06 | 443 | 108 | 11 | CID000000896 |
| Drug | 9-beta-D-arabinofuranosylguanine | DOCK1 DOCK4 RAN SGCB SLC25A14 ACTB ACTG1 APLP1 GRM3 TUBA4A RAB38 MTOR LRBA MOCS1 VAV1 | 1.05e-05 | 843 | 108 | 15 | CID000000765 |
| Drug | androstan-3-ol | 1.14e-05 | 160 | 108 | 7 | CID000092877 | |
| Drug | magnesium | RAN ENPP7 FMO2 MYO5A PPM1D ENPP1 ACTB ACTG1 GRIA4 GRIN2A TUBA4A NAMPT NUDT10 FGFR2 GRIN3A LRBA CABIN1 MOCS1 RPL11 | 1.39e-05 | 1325 | 108 | 19 | CID000000888 |
| Drug | HU-211 | 1.74e-05 | 114 | 108 | 6 | CID000107778 | |
| Drug | 1-aminoindan-1,5-dicarboxylic acid | 1.76e-05 | 33 | 108 | 4 | CID000002071 | |
| Drug | L-Glutamic Acid | 1.80e-05 | 68 | 108 | 5 | DB00142 | |
| Drug | felbamate | 2.07e-05 | 70 | 108 | 5 | CID000003331 | |
| Drug | adenosine 5'-tetraphosphate | 2.23e-05 | 2 | 108 | 2 | ctd:C017991 | |
| Drug | diadenosine 5',5''''-P1,P6-hexaphosphate | 2.23e-05 | 2 | 108 | 2 | ctd:C070070 | |
| Drug | adenosine 5'-pentaphosphate | 2.23e-05 | 2 | 108 | 2 | ctd:C048567 | |
| Drug | methyl ethyl ketone | EPRS1 RPS6KA5 ENPP1 ACTB ACTG1 CASP7 STAT5A MTOR FGFR2 LRBA CABIN1 KIF17 | 2.26e-05 | 587 | 108 | 12 | CID000006569 |
| Drug | crisamicin A | 2.87e-05 | 13 | 108 | 3 | CID000125855 | |
| Drug | AC1Q3ZOL | 3.23e-05 | 258 | 108 | 8 | CID000002376 | |
| Drug | ketamine | 3.61e-05 | 262 | 108 | 8 | CID000003821 | |
| Drug | MEK1/2 inhibitor | 3.82e-05 | 193 | 108 | 7 | CID009549284 | |
| Drug | Nitrofural [59-87-0]; Down 200; 20.2uM; HL60; HT_HG-U133A | 3.82e-05 | 193 | 108 | 7 | 2459_DN | |
| Drug | Tolfenamic acid [13710-19-5]; Up 200; 15.2uM; HL60; HG-U133A | 4.49e-05 | 198 | 108 | 7 | 1437_UP | |
| Drug | thiokynurenic acid | 4.53e-05 | 15 | 108 | 3 | CID003035667 | |
| Drug | HNMPA-(AM)3; Up 200; 5uM; PC3; HG-U133A | 4.64e-05 | 199 | 108 | 7 | 583_UP | |
| Drug | paraquat | 4.64e-05 | 199 | 108 | 7 | CID000015938 | |
| Drug | NSC611747 | 4.65e-05 | 352 | 108 | 9 | CID000002534 | |
| Drug | Joro spider toxin | 5.12e-05 | 43 | 108 | 4 | CID000119582 | |
| Drug | memantine | 5.61e-05 | 86 | 108 | 5 | CID000004054 | |
| Drug | AC1L8FNU | 5.62e-05 | 44 | 108 | 4 | CID000425429 | |
| Drug | philanthotoxin | 6.14e-05 | 45 | 108 | 4 | CID000115201 | |
| Drug | pyrophosphate | EPRS1 MYO5A SGCB ENPP1 NUDT11 NAMPT ASNS NUDT10 HAL ALDH5A1 MOCS1 IP6K2 | 6.44e-05 | 654 | 108 | 12 | CID000001023 |
| Drug | Thapsigargin | EPRS1 SGCB SLC25A14 ACTG1 CASP7 MCM4 MCM7 PGRMC1 GRPEL2 NUP205 RAB38 MYOF NUDT11 ASNS UBR3 SEC63 ALDH5A1 YIPF3 | 6.44e-05 | 1353 | 108 | 18 | ctd:D019284 |
| Drug | tacrine | 6.50e-05 | 144 | 108 | 6 | CID000001935 | |
| Drug | N-methyl-DL-aspartic acid | SGCB APLP1 GRIA4 GRIN2A GRM3 CHRNA1 MTOR ABCB8 GRIN3A LRBA CABIN1 KIF17 | 6.53e-05 | 655 | 108 | 12 | CID000004376 |
| Drug | Felbamate | 6.67e-05 | 3 | 108 | 2 | DB00949 | |
| Drug | cyclohexamine | 6.67e-05 | 3 | 108 | 2 | CID000016622 | |
| Drug | littorine | 6.67e-05 | 3 | 108 | 2 | CID000443005 | |
| Drug | S-312-d | 6.67e-05 | 3 | 108 | 2 | CID000129003 | |
| Drug | AC1NQAN2 | 6.72e-05 | 17 | 108 | 3 | CID005193003 | |
| Drug | Fm 4-64 | 6.98e-05 | 90 | 108 | 5 | CID002733635 | |
| Drug | aurintricarboxylic acid | 7.36e-05 | 91 | 108 | 5 | CID000002259 | |
| Drug | SB203580 | RPS6KA5 MYO5A SGCB PPM1D ACTB ACTG1 CASP7 ACVR2A STAT5A NAMPT MTOR LRBA CABIN1 | 7.42e-05 | 771 | 108 | 13 | CID000176155 |
| Drug | caffeine | ENPP7 CYP2C9 PDE6C CYP2C18 ENPP1 GRIA4 GRIN2A GRM3 CHRNA1 ARG1 LRBA | 7.47e-05 | 562 | 108 | 11 | CID000002519 |
| Drug | MNQX | 8.04e-05 | 18 | 108 | 3 | CID000130818 | |
| Drug | NSC226080 | RPS6KA5 MYO5A PPM1D ACTB ACTG1 MCM7 ACVR2A STAT5A DOCK5 RUVBL1 MTOR FGFR2 CABIN1 | 8.55e-05 | 782 | 108 | 13 | CID000005040 |
| Drug | tetramethylrhodamine | 9.32e-05 | 50 | 108 | 4 | CID000065219 | |
| Drug | IDRA 21 | 1.12e-04 | 20 | 108 | 3 | CID000003688 | |
| Drug | sulphoxide | 1.21e-04 | 101 | 108 | 5 | CID000008442 | |
| Drug | MDL 28170 | 1.26e-04 | 54 | 108 | 4 | CID000072430 | |
| Drug | CX546 | 1.30e-04 | 21 | 108 | 3 | CID000002890 | |
| Drug | AC1L1B62 | 1.30e-04 | 21 | 108 | 3 | CID000001299 | |
| Drug | sunifiram | 1.33e-04 | 4 | 108 | 2 | CID004223812 | |
| Drug | AZD 1480 | 1.33e-04 | 4 | 108 | 2 | ctd:C545606 | |
| Drug | 4-(chloromethyl)-3-methoxy-5-methylisoxazole | 1.33e-04 | 4 | 108 | 2 | CID011105661 | |
| Drug | AC1L3XS1 | 1.33e-04 | 4 | 108 | 2 | CID000124033 | |
| Drug | 3-isoxazolol | 1.33e-04 | 4 | 108 | 2 | CID009964065 | |
| Drug | P(1),P(5)-di(adenosine-5'-)pentaphosphate | 1.33e-04 | 4 | 108 | 2 | ctd:C012275 | |
| Drug | H2O2 | EPRS1 CLCA4 RPS6KA5 SGCB PPM1D ACTB ACTG1 CASP7 APLP1 DOCK5 NAMPT MTOR HAL LRBA CABIN1 PRDM16 | 1.42e-04 | 1183 | 108 | 16 | CID000000784 |
| Drug | orphenadrine | 1.45e-04 | 56 | 108 | 4 | CID000004601 | |
| Drug | NS 102 | 1.50e-04 | 22 | 108 | 3 | CID005282252 | |
| Drug | CX516 | 1.50e-04 | 22 | 108 | 3 | CID000148184 | |
| Drug | PP-IP(5 | 1.50e-04 | 22 | 108 | 3 | CID000127296 | |
| Drug | FTY720 | 1.52e-04 | 106 | 108 | 5 | CID000107969 | |
| Drug | Buspirone | RAN ACTB AS3MT ACTG1 CASP7 MCM7 LCP1 TUBA4A RAB38 FGFR2 SEC63 | 1.82e-04 | 622 | 108 | 11 | ctd:D002065 |
| Drug | CGP 39653 | 1.95e-04 | 24 | 108 | 3 | CID006437837 | |
| Drug | imatinib | 2.11e-04 | 430 | 108 | 9 | CID000005291 | |
| Drug | AC1L1YEG | 2.21e-04 | 5 | 108 | 2 | CID000063114 | |
| Drug | Chicago acid | 2.21e-04 | 5 | 108 | 2 | CID000065740 | |
| Drug | CHEBI:570577 | 2.21e-04 | 5 | 108 | 2 | CID011334126 | |
| Drug | 1-BCP | 2.21e-04 | 5 | 108 | 2 | CID000001370 | |
| Drug | irampanel | 2.21e-04 | 5 | 108 | 2 | CID003038472 | |
| Drug | LY395153 | 2.21e-04 | 5 | 108 | 2 | CID000656707 | |
| Drug | Acamprosate | 2.21e-04 | 5 | 108 | 2 | DB00659 | |
| Drug | Memantine | 2.21e-04 | 5 | 108 | 2 | DB01043 | |
| Drug | Ac-DNLD-Cho | 2.21e-04 | 5 | 108 | 2 | CID010458686 | |
| Drug | beta-N-oxalylaminoalanine | 2.21e-04 | 5 | 108 | 2 | CID000107978 | |
| Drug | 5-h PCA | 2.21e-04 | 5 | 108 | 2 | CID000129091 | |
| Drug | gavestinel | 2.21e-04 | 25 | 108 | 3 | CID006450546 | |
| Drug | strychnine HCl | 2.27e-04 | 181 | 108 | 6 | CID000005304 | |
| Drug | Kaletra | 2.79e-04 | 27 | 108 | 3 | CID011979606 | |
| Drug | L-689,560 | 2.79e-04 | 27 | 108 | 3 | CID000121918 | |
| Drug | NVP & EFV | 2.81e-04 | 121 | 108 | 5 | CID000492400 | |
| Drug | AC1L2A54 | 3.03e-04 | 191 | 108 | 6 | CID000068636 | |
| Drug | D-luciferin | 3.09e-04 | 68 | 108 | 4 | CID005376812 | |
| Drug | C-PP | 3.12e-04 | 28 | 108 | 3 | CID000001228 | |
| Drug | aptiganel | 3.12e-04 | 28 | 108 | 3 | CID000060839 | |
| Drug | Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; HL60; HT_HG-U133A | 3.21e-04 | 193 | 108 | 6 | 1268_DN | |
| Drug | 13,14-dihydro-15-ketoprostaglandin E2 | 3.27e-04 | 125 | 108 | 5 | CID004307039 | |
| Drug | Hydralazine hydrochloride [304-20-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 108 | 6 | 2311_UP | |
| Drug | Rp-cAMPS | 3.30e-04 | 194 | 108 | 6 | CID006426631 | |
| Drug | Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 108 | 6 | 3867_DN | |
| Drug | Probenecid [57-66-9]; Up 200; 14uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 108 | 6 | 2825_UP | |
| Drug | 4',5-dihydroxydiclofenac | 3.30e-04 | 6 | 108 | 2 | CID003052567 | |
| Drug | mono-OH | 3.30e-04 | 6 | 108 | 2 | CID000183679 | |
| Drug | YM928 | 3.30e-04 | 6 | 108 | 2 | CID006918393 | |
| Drug | 2-hydroxy-1-(2-((9-(4-methylcyclohexyl)-9H-pyrido(4',3'-4,5)pyrrolo(2,3-d)pyrimidin-2-yl)amino)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl)ethanone | 3.30e-04 | 6 | 108 | 2 | ctd:C000589290 | |
| Drug | 3'-hydroxydiclofenac | 3.30e-04 | 6 | 108 | 2 | CID000112230 | |
| Disease | restless legs syndrome (implicated_via_orthology) | 2.49e-06 | 8 | 106 | 3 | DOID:0050425 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 5.31e-06 | 10 | 106 | 3 | DOID:10486 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome | 1.28e-05 | 2 | 106 | 2 | cv:C1853623 | |
| Disease | Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation | 1.28e-05 | 2 | 106 | 2 | C1855722 | |
| Disease | Fryns-Aftimos Syndrome | 1.28e-05 | 2 | 106 | 2 | C1853623 | |
| Disease | X-21258 measurement | 3.83e-05 | 3 | 106 | 2 | EFO_0800802 | |
| Disease | metabolonic lactone sulfate measurement | 4.19e-05 | 19 | 106 | 3 | EFO_0800659 | |
| Disease | leukemia (implicated_via_orthology) | 4.19e-05 | 19 | 106 | 3 | DOID:1240 (implicated_via_orthology) | |
| Disease | Schizophrenia | DOCK4 ACTB GRIA4 GRIN2A GRM3 ADAMTS12 RTKN2 MTOR FGFR2 GRIN3A KIF17 TNXB | 8.01e-05 | 883 | 106 | 12 | C0036341 |
| Disease | Child Development Disorders, Specific | 1.54e-04 | 29 | 106 | 3 | C0085997 | |
| Disease | Child Development Deviations | 1.54e-04 | 29 | 106 | 3 | C0085996 | |
| Disease | Developmental Disabilities | 1.70e-04 | 30 | 106 | 3 | C0008073 | |
| Disease | glycine conjugate of C10H14O2 (1) measurement | 2.65e-04 | 7 | 106 | 2 | EFO_0800655 | |
| Disease | Uveoretinal Coloboma | 2.65e-04 | 7 | 106 | 2 | C4554007 | |
| Disease | Moyamoya disease (implicated_via_orthology) | 3.53e-04 | 8 | 106 | 2 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 3.53e-04 | 8 | 106 | 2 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 3.53e-04 | 8 | 106 | 2 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 3.53e-04 | 8 | 106 | 2 | DOID:14004 (implicated_via_orthology) | |
| Disease | Congenital ocular coloboma (disorder) | 4.53e-04 | 9 | 106 | 2 | C0009363 | |
| Disease | Liver Cirrhosis, Experimental | 4.81e-04 | 774 | 106 | 10 | C0023893 | |
| Disease | Congenital neurologic anomalies | 5.65e-04 | 10 | 106 | 2 | C0497552 | |
| Disease | Cranioschisis | 5.65e-04 | 10 | 106 | 2 | C0265541 | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 5.65e-04 | 10 | 106 | 2 | DOID:13832 (implicated_via_orthology) | |
| Disease | ureteral obstruction (biomarker_via_orthology) | 5.73e-04 | 45 | 106 | 3 | DOID:5199 (biomarker_via_orthology) | |
| Disease | adipic acid mesurement | 9.72e-04 | 13 | 106 | 2 | EFO_0010455 | |
| Disease | Animal Mammary Neoplasms | 1.75e-03 | 142 | 106 | 4 | C0024667 | |
| Disease | Mammary Carcinoma, Animal | 1.75e-03 | 142 | 106 | 4 | C1257925 | |
| Disease | BRCAX breast cancer | 2.33e-03 | 20 | 106 | 2 | EFO_0009443 | |
| Disease | Mammary Neoplasms, Experimental | 2.40e-03 | 155 | 106 | 4 | C0024668 | |
| Disease | Craniofacial Abnormalities | 2.46e-03 | 156 | 106 | 4 | C0376634 | |
| Disease | Dermatologic disorders | 2.52e-03 | 75 | 106 | 3 | C0037274 | |
| Disease | nose morphology measurement, mouth morphology measurement | 2.57e-03 | 21 | 106 | 2 | EFO_0007843, EFO_0007955 | |
| Disease | Carcinomatosis | 2.88e-03 | 163 | 106 | 4 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 2.88e-03 | 163 | 106 | 4 | C0205697 | |
| Disease | Undifferentiated carcinoma | 2.88e-03 | 163 | 106 | 4 | C0205698 | |
| Disease | Anaplastic carcinoma | 2.88e-03 | 163 | 106 | 4 | C0205696 | |
| Disease | Carcinoma | 2.94e-03 | 164 | 106 | 4 | C0007097 | |
| Disease | sciatic neuropathy (implicated_via_orthology) | 3.08e-03 | 23 | 106 | 2 | DOID:11446 (implicated_via_orthology) | |
| Disease | Cleft Palate | 3.14e-03 | 81 | 106 | 3 | C0008925 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VDGEIILHLYDKGGI | 96 | P08243 | |
| LKKLGPDYVDLFIIH | 106 | Q5T2L2 | |
| VKGIGDELYNPETHK | 341 | Q9H7F0 | |
| KRGILTLKYPIEHGI | 61 | P60709 | |
| KRGILTLKYPIEHGI | 61 | P63261 | |
| AYLHEDIPGLKDGHK | 301 | P27037 | |
| KDDYLLPGVKLGVHI | 81 | Q14832 | |
| KKPYGAISHGVVEVD | 606 | P51693 | |
| EYGKHEELLSKPNGI | 711 | Q9NRK6 | |
| YIKEGLEKPVEIIRH | 601 | Q9UHI6 | |
| YNHLAGELDPKAIEK | 466 | Q9NVE4 | |
| GKPEIKILHIDDYEL | 531 | Q8N608 | |
| VDYPLDGEKILHILG | 246 | Q9NZ32 | |
| IEPVKKHPLVEGGYH | 176 | P58397 | |
| DVDPGEHYILKTLGI | 181 | P05089 | |
| HAEYLEKLKLGGSPT | 136 | Q8NFP7 | |
| EKKYVATLGVEVHPL | 36 | P62826 | |
| KEHLYKLLVIGDLGV | 6 | P57729 | |
| IGELYKKNPFHLELA | 446 | Q92621 | |
| DYGGVKKIHIPSEKI | 91 | P02708 | |
| GIPVEELFKLLKEGH | 706 | P21802 | |
| LAPSIYEHEDIKKGI | 466 | P33991 | |
| AYPLKGDHGIVDIVD | 86 | Q9UHH9 | |
| DALKRDKDAIYGHPL | 71 | O14770 | |
| HDGTADGDKPKILLY | 3141 | Q2LD37 | |
| TVERIHVGKKYGDIP | 46 | O15116 | |
| KYEGKVLHGDLIDFV | 471 | P05160 | |
| KHIGIKYKIAIVPDG | 456 | P48058 | |
| IGAEDLKEGKPYLVL | 211 | P13796 | |
| LRLEDLFKLGEPYHK | 141 | Q9HCM2 | |
| ELLKIKADIIYPGHG | 186 | Q53H82 | |
| HVGKLLKEGEEPTVY | 166 | O00264 | |
| IDYILHGKEEIKVIP | 321 | P51160 | |
| KEAIIGVGKEDYPHT | 156 | Q9ULH7 | |
| GKDEKGRKIPEYLIH | 41 | Q8N5Y2 | |
| LEYDHPLKKLTEEFG | 181 | P55160 | |
| KKIDPKILAYTEGLH | 2116 | P50851 | |
| DGLKREKDEIYGHPL | 51 | Q99687 | |
| VAEEKIIKHETLPYG | 646 | P22413 | |
| QHYDLDLKDKPLGEG | 421 | O75582 | |
| HAEYLEKLKLGGSPT | 136 | Q96G61 | |
| LDPQKHKYIILGSDG | 301 | O15297 | |
| HGLEKLTPIGDKYDP | 161 | Q8TAA5 | |
| KVKHYLILPSEEEGR | 476 | Q14451 | |
| APEIYGHEDVKKALL | 341 | P33993 | |
| EGIHKAIELGYNPVK | 201 | Q9NZB8 | |
| DGLKRDKDEIYGHPL | 51 | A8K0S8 | |
| EKIYEELSGIHDPKL | 771 | Q8TCU5 | |
| HPYLIKGAEEKILGE | 1146 | Q3L8U1 | |
| ADAKYVLEAHGLKPV | 281 | P42357 | |
| VGVELPVYDITKKHL | 176 | Q5SVS4 | |
| DEKEGLKHPGLILKY | 76 | Q9Y6J0 | |
| PASYIHLKEAIVEGK | 61 | Q14185 | |
| VKEYILSHPEDGEKI | 1526 | Q8N1I0 | |
| EGKLLEKAIHPGAGY | 476 | Q9H7D0 | |
| PELHKELLKYGFNVI | 91 | Q7Z4T8 | |
| FIHGYIEKLGEAGIK | 131 | Q9HBK9 | |
| YGKDGVTPIKDLTAH | 151 | P55210 | |
| GDKHDLEPSGLVPKY | 131 | Q8TC29 | |
| YKHPDGFEGKRILVI | 176 | Q99518 | |
| LKPIVVLHGYEAVKE | 71 | P33260 | |
| LKPIVVLHGYEAVKE | 71 | P11712 | |
| KLLEPVDHGKIEYEP | 316 | Q7L014 | |
| GRLEKVYDALKDAHP | 291 | Q6UWV6 | |
| PEGVHALYEDILEGK | 56 | Q9NUM3 | |
| LKEHPEKGVYVKGLS | 161 | Q9P2E2 | |
| GTHEELLKKGGLYAE | 691 | Q9NUT2 | |
| RVLGLLGALDPYKHK | 886 | P42345 | |
| KVREHKVLGPYVDGL | 171 | Q9H1H9 | |
| LHAKELYNVLPGGEK | 141 | Q8N461 | |
| VLYPASEPLHDEKGK | 486 | Q8IZC4 | |
| KEGLPVALDKHILGF | 176 | Q9Y224 | |
| YEHLITKPVLGKDED | 626 | P07814 | |
| SGKPLKEAHGEILYS | 146 | P51649 | |
| AIYEAGKEHGLKPVV | 81 | P08582 | |
| GKEHGLKPVVGEVYD | 86 | P08582 | |
| LKEIGENVHIYLIGK | 231 | Q9NVX7 | |
| EPGEELLVHVKEGVY | 201 | Q9HAZ2 | |
| VGEDGFLLKIKLGHY | 76 | P51692 | |
| EKYDGHLPIEIKAVP | 106 | P43490 | |
| LYELVKQKGLPDAHL | 911 | O95785 | |
| VCDKKAPYEHLIIDG | 376 | O75925 | |
| KAGYIPIDEDRLHKT | 41 | Q16585 | |
| PEGEIFKEPYLDIHK | 256 | Q96QV1 | |
| VGEDGFLLKIKLGHY | 76 | P42229 | |
| EKGEYIHFTPDLLLG | 126 | Q14CN2 | |
| LLGELEKDPKLVYHI | 346 | Q9UKZ1 | |
| EKDPKLVYHIGLTPA | 351 | Q9UKZ1 | |
| KVIGLPGHQEVEVKY | 746 | Q9BXT8 | |
| VGVELPVYDITKKHL | 211 | O95258 | |
| EELAGLPGLYHVKLL | 271 | Q6B0B8 | |
| EHIDLGIKYDPSIGI | 111 | P62913 | |
| IGKYLLLEPLEGDHV | 61 | Q92519 | |
| LEEVKIPHGVKLVCY | 461 | Q6ZMY3 | |
| SLAHYGRPKIDGELK | 396 | P15498 | |
| DGVTISGLEPDHKYK | 3111 | P22105 | |
| LLSLKYHPDKGGDEV | 126 | Q9UGP8 | |
| EYHKEEPITSLGKEL | 421 | Q9H788 | |
| YDAKEKIAPLPLEGH | 311 | Q9P0W8 | |
| ILKHVIGDYKDIFPD | 111 | Q96MG7 | |
| EAEEYVPLPKGDVHK | 216 | Q9Y265 | |
| YHKVVEGILDTLEGP | 296 | Q9GZM5 | |
| VISELFKGKLYHEEG | 1611 | Q6ZT12 | |
| KLHLYEQGGRLKEPL | 431 | Q9NPG3 | |
| LRDKPHVNVEYGKGI | 281 | A6NK53 | |
| ILLGPKGKAKSYHEI | 326 | Q9Y6R1 | |
| HELITKYGKLEPLAE | 321 | Q5QJ74 | |
| LDIRHEKIPIGEKSY | 176 | Q8NDW4 | |
| GHYTIGKEIIDPVLD | 106 | P68366 | |
| YKPGDKVLLLHLEEG | 31 | Q9Y4I1 | |
| TLGKKVIEDRDHYIP | 1581 | Q9NZM1 | |
| KIYTIDGEKEPGFHL | 1116 | Q12879 |